Ying Han

Ying Han

Auto-generated profile, based on publicly available information

Ying Han

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China (W.J., J.M., J.F., Y.H., Z.L.).

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in International Journal of Stroke
Verified
Journal Article
Closed access
MWMeng Wang
Meng Wang
YHYing Han
Ying Han
CWChun-Juan Wang
Chun-Juan Wang
TXTao Xue
Tao Xue
HGHongqiu Gu
Hongqiu Gu
YWYongjun Wang
Yongjun Wang
Background: Fine particulate matter (PM2.5) is a risk factor for stroke, and patients with pre-existing diseases appear to be particularly susceptible. We conducted a case-crossover study to examine the association between short-term exposure to fine particulate matter (PM2.5) and hospital admission for stroke in individuals with atrial fibrillation (AF), hypertension, diabetes, or hyperlipidemia. Methods: Patients diagnosed with acute ischemic stroke (AIS) were recruited from 2015 to 2017 in Chinese Stroke Center Alliances. We estimated daily PM2.5 average exposures with a spatial resolution of 0.1° using a data assimilation approach combining satellite measurements, air model simulations, and monitoring values. Conditional logistic regression was used to assess PM2.5-related stroke risk in patients with pre-existing medical co-morbidities. Results: A total of 155,616 patients diagnosed with AIS were admitted. Patients with a history of AF ( n = 15,430), hypertension ( n = 138,220), diabetes ( n = 43,737), or hyperlipidemia ( n = 16,855) were assessed separately. A 10 µg/m3 increase in daily PM2.5 was associated with a significant increase in AIS for individuals with AF at lag 4 (odds ratio (OR), 1.008; 95% confidence interval (CI), 1.002–1.014), and with hypertension (OR, 1.008; 95% CI, 1.006–1.010), diabetes (OR, 1.006; 95% CI, 1.003–1.010), and hyperlipidemia (OR, 1.007; 95% CI, 1.001–1.012) at lags 0–7. Elderly (⩾ 65 years old) and female patients with AF had significantly higher associations at lag 5 (OR, 1.009; 95% CI, 1.002–1.015) and lag 5 (OR, 1.010; 95% CI, 1.002–1.018), respectively. Conclusion: Short-term exposure to PM2.5 is significantly associated with hospital admission for stroke in individuals with pre-existing medical histories, especially in older or female patients with AF. Preventive measures to reduce PM2.5 concentrations are particularly important in individuals with other medical co-morbidities.

1 August 2025 in Stroke
Verified
Journal Article
Closed access
WJWeili Jia
Weili Jia
YZYijun Zhou
Yijun Zhou
JMJiawen Mao
Jiawen Mao
JFJinru Feng
Jinru Feng
YHYing Han
Ying Han
ZPZi-Xiao Li PhD
Zi-Xiao Li PhD
BACKGROUND: This study aimed to investigate neurophysiological mechanisms underlying functional impairment and recovery after acute ischemic stroke using transcranial magnetic stimulation combined with electroencephalography, focusing on interhemispheric interactions and oscillatory dynamics. METHODS: This single-center case-control study (December 2022 to May 2024) included 19 ischemic stroke patients within 14 days of symptom onset (mean age, 47.95±12.41 years; 15 [79%] men) with 3-month poststroke follow-up. Sixteen age-matched healthy controls (53.56±9.83 years; 12 [80%] men) were included. Transcranial magnetic stimulation-evoked electroencephalography potentials, local mean field power during 25 ms and 35 ms (local mean field power 25 –35 ms ), and power spectral density of the ipsilesional primary motor cortex (ilM1) were calculated when single-pulse transcranial magnetic stimulation was sequentially applied to the contralesional M1 (clM1) and ilM1. Spearman correlation analysis evaluated associations between transcranial magnetic stimulation combined with electroencephalography parameters and clinical outcomes: Fugl-Meyer assessment, Fugl-Meyer assessment-upper extremity subscale, National Institutes of Health Stroke Scale, and National Institutes of Health Stroke Scale changes from baseline to 3 months poststroke. RESULTS: Stroke patients exhibited simplified transcranial magnetic stimulation-evoked electroencephalography potential waveforms with reduced amplitudes compared with healthy controls. The contralesional resting motor threshold of stroke patients was significantly lower compared with healthy controls ( t =−2.79; P =0.009). The contralesional resting motor threshold was positively associated with the local mean field power 25 –35 ms of ilM1 with stimulation on ilM1 ( r =0.482; P =0.018). The power and power spectral density of β oscillations were negatively associated with the Fugl-Meyer assessment ( r =−0.557, P =0.014; r =−0.417, P =0.038, respectively) and Fugl-Meyer assessment-upper extremity ( r =−0.503, P =0.014; r =−0.389, P =0.05, respectively), but the power of β oscillations was positively associated with changes in the National Institutes of Health Stroke Scale ( r =0.507; P =0.027) with stimulation on clM1. CONCLUSIONS: Increased excitability of the clM1 is associated with decreased excitability of the ilM1. The inhibition of β oscillations in the ilM1 by the clM1 serves as a biomarker for poststroke functional impairment and recovery. Neuromodulation of the clM1 to enhance the β oscillations of ilM1 may be a promising treatment strategy.

22 May 2024 in Angiology
Verified
Journal Article
Closed access
MWMeng Wang
Meng Wang
YHYing Han
Ying Han
QZQi Zhou
Qi Zhou
CWChun-Juan Wang
Chun-Juan Wang
XMXia Meng
Xia Meng
ZLZi-Xiao Li
Zi-Xiao Li
The present study aimed to develop a model to predict functional disability at 3 months in patients with acute ischemic stroke (AIS) ( n = 5,406). The primary outcome was functional disability (modified Rankin Scale [mRS] >2) at 3 months. A prediction model including blood biomarkers was developed based on a multivariable logistic regression model, which was internally validated by the 100-time bootstrap method. A nomogram and a web-based calculator were developed for usage in clinical practice. At 3 months, 11% (638/5,406) of the patients had functional disability. Seven independent predictors of functional disability at 3 months were incorporated into the FAITHS 2 model (fasting plasma glucose, age, interleukin-6, stroke history, National Institute of Health Stroke Scale [NIHSS] at admission, sex, and systolic blood pressure). The Area Under Curves (AUCs) were 0.814 (95% confidence interval [CI] 0.796–0.832) and 0.808 (95% CI 0.806–0.810), and the Brier scores were 0.088 ± 0.214 and 0.089 ± 0.003 for the derivation cohort and internal validation, respectively, showing optimal performance of the model. The FAITHS 2 model has excellent potential to be a dependable application for individualized clinical decision making.